Profile for Australia Patent: 2015202617
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2015202617
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,931,377 | Jun 30, 2029 | Mallinckrodt Ireland | INOMAX | nitric oxide |
| 11,931,377 | Dec 30, 2029 | Mallinckrodt Ireland | INOMAX | nitric oxide |
| 8,282,966 | Dec 30, 2029 | Mallinckrodt Ireland | INOMAX | nitric oxide |
| 8,293,284 | Dec 30, 2029 | Mallinckrodt Ireland | INOMAX | nitric oxide |
| 8,431,163 | Dec 30, 2029 | Mallinckrodt Ireland | INOMAX | nitric oxide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
